Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism

OBJECTIVE: Increased hepatic de novo lipogenesis (DNL) is suggested to be an underlying cause in the development of nonalcoholic fatty liver disease and/or insulin resistance. It is suggested that omega-3 fatty acids (FA) lower hepatic DNL. We investigated the effects of omega-3 FA supplementation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Charlotte J, Pramfalk, Camilla, Charlton, Catriona A, Gunn, Pippa J, Cornfield, Thomas, Pavlides, Michael, Karpe, Fredrik, Hodson, Leanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078804/
https://www.ncbi.nlm.nih.gov/pubmed/32188593
http://dx.doi.org/10.1136/bmjdrc-2019-000871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078804/
https://www.ncbi.nlm.nih.gov/pubmed/32188593
http://dx.doi.org/10.1136/bmjdrc-2019-000871

Ejemplares similares